Providing comprehensive care for patients with Friedreich’s Ataxia (FA), a rare, progressive neurogenetic condition, while advancing research to improve the lives of all individuals with FA.
This week’s In the News features firearms research, stillbirths during COVID, donations to the Friedreich’s Ataxia Center of Excellence, and postdocs highlighted for diversity.
The Wilson Lab studies the inherited neuro- and cardio-degenerative mitochondrial disorder, Friedreich ataxia (FA). The lab also constructed the first random shRNA-expressing libraries and is using these libraries for drug discovery in a variety of disorders.
Dr. Lynch maintains a dynamic program that involves clinical, translational, and basic science research efforts focused on the rare disease Friedreich ataxia.
